Sialorrhea is a relatively common symptom in idiopathic Parkinson's disease and related conditions for which most of the accepted treatments are either highly invasive or may cause substantial systemic side effects. This study describes an open-label pilot study of sublingual atropine drops for the treatment of sialorrhea in 7 patients (6 with Parkinson's disease, 1 with progressive supranuclear palsy). Participants demonstrated statistically significant declines in saliva production, both objectively and subjectively. Self-reported drooling severity showed a significant decline between baseline and 180 minutes, t(6) = 3.240 P < 0.025 (eta(2) = 0.636), and between baseline and 1 week, t(6) = 4.583 P < 0.005 (eta(2) = 0.778). Objectively measured saliva production decreased significantly between baseline and the 1-week follow-up, t(6) = 2.711 P < 0.05 (eta(2) = 0.551). Delirium occurred in 1 patient (concurrent with a urinary tract infection), and 2 patients experienced worsening of hallucinations (active hallucinosis was concealed by both individuals to allow participation in the trial). The remaining trial participants did not experience any anticholinergic side effects. This trial shows that, in selected patient populations, sublingual atropine is a simple and inexpensive treatment for sialorrhea associated with parkinsonism.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.10276DOI Listing

Publication Analysis

Top Keywords

sublingual atropine
12
pilot study
8
parkinson's disease
8
side effects
8
treatment sialorrhea
8
saliva production
8
sialorrhea
4
atropine sialorrhea
4
sialorrhea secondary
4
secondary parkinsonism
4

Similar Publications

Case Report: Painful left bundle branch block syndrome complicated with vasovagal syncope.

Front Cardiovasc Med

January 2025

Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Background: Painful left bundle branch block (LBBB) syndrome is an uncommon disease that is defined as intermittent episodes of angina associated with simultaneous LBBB changes on an electrocardiogram (ECG) with the absence of flow-limiting coronary artery disease or ischemia on functional testing. Vasovagal syncope (VVS) is the most common cause of syncope and can be provoked by sublingual nitroglycerin (NTG). Herein, we report a case of painful LBBB syndrome complicated with VVS, which was misdiagnosed as acute coronary syndrome and cardiogenic shock.

View Article and Find Full Text PDF

Sublingual administration of atropine eye drops for treating sialorrhea after stroke: A randomized controlled trial.

J Stroke Cerebrovasc Dis

December 2024

Traditional Chinese Medicine Department, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang City, China. Electronic address:

Article Synopsis
  • Sialorrhea, or excessive saliva production, is common in stroke patients with swallowing disorders, and atropine sulfate can reduce saliva by blocking certain receptors.
  • A study at Xiangyang No. 1 People's Hospital tested sublingual atropine eye drops on 100 stroke patients, comparing results with a control group receiving standard rehabilitation.
  • Results showed a significant improvement in sialorrhea scores for the group using atropine, with no notable increase in adverse events, indicating that this method is effective, safe, and non-invasive for treatment.
View Article and Find Full Text PDF

We discuss a case with off-label sublingual administration of atropine for clozapine-induced sialorrhea (CIS) after failure of two commonly used agents to manage CIS. Atropine had a demonstrable efficacy, as measured by means of sialometry conducted before and after its administration. The salivary rate, initially measured at 0.

View Article and Find Full Text PDF
Article Synopsis
  • * He was treated with sublingual atropine eye drops, which reduced the need for intravenous atropine.
  • * This treatment allowed for quick recovery, enabling him to walk without help and be discharged.
View Article and Find Full Text PDF

Parotid hypersalivation after inferior salivatory nucleus glutamate/NMDA receptor excitation in the rat.

Physiol Behav

June 2024

Department of Psychobiology and Mind, Brain and Behaviour Research Centre (CIMCYC), University of Granada, Granada 18071, Spain. Electronic address:

Although salivation is essential during eating behavior, little is known about the brainstem centers that directly control the salivary glands. With regard to the inferior salivatory nucleus (ISN), the site of origin of the parasympathetic preganglionic cell bodies that innervate the parotid glands, previous anatomical studies have located it within the rostrodorsal medullary reticular formation. However, to date there is no functional data that shows the secretory nature of the somas grouped in this region.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!